Genesis Research halted from trading pending statement

Genesis Research and Development, which in July abandoned plans to merge with an unlisted Australian company, had its shares halted from trading pending an announcement.

The company suspended operations in May 2010 and laid off its entire staff.

In July this year it placed 9.1 million shares, which it said gave it enough funds to remain listed while it considers further investments.

The shares last traded at 1.8 cents, valuing the company at $980,000, and have declined 40% in the past year.

In July, Genesis called off a proposed merger with Australia-based Mariposa Health, an unlisted public pharmaceutical development company.

(BusinessDesk)


Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

Comments & Questions

Commenter icon key: Subscriber Verified

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

NZ Market Snapshot

Forex

Sym Price Change
USD 0.7017 0.0015 0.21%
AUD 0.9383 0.0008 0.09%
EUR 0.6272 0.0041 0.66%
GBP 0.5415 0.0024 0.45%
HKD 5.4637 0.0130 0.24%
JPY 78.4390 0.7970 1.03%

Commods

Commodity Price Change Time
Gold Index 1255.5 -9.660 2017-05-23T00:
Oil Brent 54.4 0.260 2017-05-23T00:
Oil Nymex 51.5 0.340 2017-05-23T00:
Silver Index 17.1 -0.050 2017-05-23T00:

Indices

Symbol Open High Last %
NZX 50 7386.0 7393.9 7384.7 0.08%
NASDAQ 6149.6 6150.9 6133.6 0.08%
DAX 12597.5 12703.7 12619.5 0.31%
DJI 20908.7 20961.1 20894.8 0.21%
FTSE 7496.3 7521.9 7496.3 -0.15%
HKSE 25415.6 25487.0 25391.3 0.05%
NI225 19647.7 19693.0 19678.3 -0.33%
ASX 5760.2 5771.3 5760.2 0.02%